Conference room at night with organized exhibit binders

Andrew J. Hillman, Dallas Compliance Expert Witness

Andrew J. Hillman (Andrew Jonathan Hillman) is a healthcare compliance expert witness and senior paralegal in Dallas, Texas, retained through counsel in federal matters. He is not an attorney.

Andrew Jonathan Hillman of Dallas, Texas, speaking at an evening event in a blue plaid suit.
Tabbed exhibit binders with brass clips
Brass loupe on highlighted documents beside a closed laptop
Empty courtroom gallery with a brass rail
Abstract overlapping serif letterforms A and H, generative still for Andrew Hillman
Andrew Hillman, Healthcare Operations Advisory and Expert Engagements
Healthcare operations advisory and expert engagements

Andrew J. Hillman

Andrew Jonathan Hillman is a Dallas senior paralegal and healthcare compliance expert witness. He also advises healthcare businesses on operations.

Andrew Hillman no longer owns or operates any healthcare facility, medical practice, or laboratory. He bills no insurer or payer. His only ongoing business activity is investing as a family office through Hillman Ventures. He advises businesses independently and is retained as an expert witness through counsel. He also works as a senior paralegal at a boutique law firm, on investigations and on personal injury and healthcare litigation support, under the supervision of its licensed attorneys. He is not an attorney and does not provide legal advice.

Andrew J. Hillman in a selfie with a young man in the stands at an arena game
Andrew Jonathan Hillman with others.
Andrew Hillman in a selfie with another man in an office
Andrew Hillman with others.
Advisory services

How Andrew Hillman advises businesses.

Advisory work for companies building, buying, or operating healthcare businesses. Each service draws on three decades of having formed, licensed, and run these operations directly. Advisory only. Andrew Hillman does not own, operate, or hold a clinical or licensure interest in any client business, and bills no insurer or payer.

Regulatory advising

Guidance on healthcare and FDA regulatory pathways, licensure, and compliance structures, including the Stark Law, the Anti-Kickback Statute, HIPAA, CLIA, and state licensure as they arise in operations and transactions.

Attorney selection

Help identifying and vetting specialized healthcare, regulatory, and transactional counsel matched to a specific matter, and coordinating their work. Andrew Hillman is not a licensed attorney and does not provide legal advice.

Due diligence

Operational and regulatory diligence on healthcare acquisitions, partnerships, and investments, including licensure, billing, and compliance exposure.

Site selection

Evaluation of locations for surgical, laboratory, pharmacy, and clinical operations against regulatory, licensure, market, and operational criteria.

Facility design

Advisory on layout, workflow, and the physical and compliance requirements of licensed surgical, laboratory, and pharmacy facilities.

Equipment negotiation

Support sourcing clinical and laboratory equipment and negotiating purchase, lease, and service terms.

Core competencies

The compliance and litigation-support practice.

Andrew Hillman's primary focus, drawn from healthcare operations and compliance engagements and from expert-witness and senior-paralegal work in federal matters nationwide, conducted through retaining counsel. He is not a licensed attorney and provides operator and compliance support, not legal opinion.

Regulatory governance

Written policies and SOPs, board reporting, and internal controls.

Vendor and contract risk

Vendor audits, service level agreement reviews, and a log of third-party risk.

Data privacy and security

State privacy laws including CCPA and CPRA, HIPAA, data-privacy workflows, and vendor data-use audits.

Internal audit and investigations

Sorting what matters first, records retention rules, and internal compliance review, under counsel.

Litigation and defense support

White-collar and regulatory defense support, evidence review, and subpoena response, under retaining counsel.

Email an engagement inquiry
Expert witness engagements since 2020

Consulting expert or testifying expert.

Separate from the advisory practice, Andrew Hillman is retained as an expert witness in either capacity. The role is fixed in writing at the outset, and the scope of any opinion is stated in the engagement agreement. He is not a licensed attorney. He offers operator testimony on healthcare business practice, drawn from having built and run these operations, not legal opinion.

  1. Pre-filing case evaluation

    Early assessment of the healthcare operations and compliance issues in a matter, including whether an operator opinion is available on the facts.

  2. Discovery and document analysis

    Review and analysis of operating records, contracts, policies, ownership documents, and billing records. Assistance framing document requests and deposition topics.

  3. Expert report preparation

    Preparation of a written report stating the opinions offered, the facts and data considered, and the basis for each opinion.

  4. Deposition and trial testimony

    Deposition testimony and testimony at hearing or trial, within the scope disclosed in the report.

Background and experience

The operating record behind the opinions.

Andrew Hillman smiling in glasses and a black sweater during an evening out in Dallas

Andrew Jonathan Hillman is a Dallas healthcare operator with three decades co-founding and running FDA-regulated surgical hospitals, ambulatory surgical centers, clinical laboratories, and pharmacy businesses. Since 2020 he has worked as an expert witness on healthcare operations, hospital business practice, and federal regulatory matters, engaged through retaining counsel.

His opinions rest on having built, licensed, staffed, and run these businesses. Where the operating record is incomplete on a given question, he states the limit rather than filling it with inference.

Engagement history and credentials can be cross-checked on his LinkedIn profile.

Outside his engagements, Andrew Hillman values time with his family, his advisory work, and his senior paralegal work with a boutique law firm, under the supervision of its licensed attorneys.

Ownership and licensure

  • Past owner and operator of a Class A retail pharmacy, a Class G administrative pharmacy, and a wholesale pharmacy distributor.
  • Past owner and operator of ambulatory surgical centers, acute care hospitals, and a rehabilitation hospital.
  • Past owner and operator of clinical and toxicology laboratories.
  • Past owner and operator of FDA-regulated medical device companies.

Companies and facilities in the record

A selection. The fuller CURRENT vs PAST list is on /ventures.

Each entity below is documented in a primary public source. The filings, clearances, and registry records are indexed on the credentials and verification page.

  • Dynacq Healthcare, Inc. (NASDAQ: DYII), a public healthcare company taken private. SEC filings under CIK 890908 include a 2013 Form 10-K and a 2014 SC 14D-9.
  • Victory Medical Center facilities, including Plano, Craig Ranch in McKinney (CMS NPI 1164867198), and South Cross in San Antonio. The Victory hospitals were acquired by Nobilis Health Corp. (SEC EDGAR CIK 1409916), reported contemporaneously by Becker's Hospital Review, Becker's ASC, and GlobeNewswire.
  • Surgery Specialty Hospitals of America, Pasadena, Texas (CMS NPI 1891718789), the facility operated under Dynacq Healthcare.
  • Bone Solutions, Inc., Southlake, Texas, an orthobiologics company with eight FDA 510(k) clearances, including K161568 and K192674.
  • United Toxicology (CMS NPI 1063707743), a toxicology laboratory.
  • Prestonwood Surgery Center (CMS NPI 1225225154) and Medical Edge Healthcare Group (CMS NPI 1063573541).
  • The Apothecary Shop pharmacies, formerly Over the Counter, and Digimed, both taken private.

Featured white paper

Authored and indexed publications

ORCID iD 0009-0001-5396-321X. Wikidata Q139969699. OpenAlex author record OpenAlex (A5139488776). ResearchGate Andrew-Hillman. DOI-registered papers are listed once, under Publications on this page.

These publications are listed to document authorship and subject-matter familiarity. Nothing in them, and nothing on this site, is a claim of FDA approval, safety, or efficacy for any product or therapy.

Targeted Osmotic Lysis (TOL) is investigational. It has not been approved by the FDA for any indication and it is not available as a treatment. Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. The publications listed above are educational and describe published scientific literature. They do not describe an available treatment, they do not report results in patients, and they do not offer access to any therapy.
Work history

Current roles. Past companies on /ventures.

Current work is below. Past companies are not repeated on this page.

CURRENT
Principal, Hillman Ventures. A Dallas biotech family office.
CURRENT
Healthcare operations advisor and expert witness, retained through counsel. Not an attorney.
PAST
Past ownership and exited companies from the public record are listed on /ventures.
Independence and ethics

How the work is conducted.

  • Current status. Andrew Hillman no longer owns or operates any healthcare facility, medical practice, or laboratory. He bills no insurer or payer. His only ongoing business activity is investing as a family office through Hillman Ventures. He advises businesses independently and is retained as an expert witness through counsel.
  • Andrew Hillman provides impartial analysis based on documented evidence. He does not tailor an opinion to the retaining party.
  • Compensation is not contingent on the outcome of any matter, and no fee is tied to a verdict, an award, or a settlement.
  • Engagements are arranged through retaining counsel under a separate written agreement.
  • Scope, current professional status, and any potential conflicts are disclosed before work begins.
  • He is not a licensed attorney. He offers operator testimony on healthcare business practice, not legal opinion.
  • Where the record does not support an opinion, he says so.
Contact and intake

Inquire about an engagement.

Counsel inquiries only. A conflicts check is run before any substantive discussion of a matter.

Email is the fastest route. The link below opens a message pre-filled with the intake items listed here.

Firm
Firm name and the office handling the matter.
Attorney contact
Name, direct line, and email of retaining counsel.
Jurisdiction
Court, venue, and case number if filed.
Case posture
Pre-filing, discovery, expert designation, or trial.
Parties
All parties and affiliates, for the conflicts check.
High-level issue
The healthcare operations or compliance question at issue.
Role sought
Consulting expert or testifying expert.
Key deadlines
Designation deadline, report deadline, discovery cutoff, and trial date.

Direct email, contact@andrewjhillman.com.

LinkedIn profile, Andrew Hillman

X profile, @AndrewHillmanTX

Wikidata Wikipedia

OpenAlex

Crunchbase

Substack

Andrew Hillman Dallas

Crunchbase

The Hillman Letter

Signature of Andrew Hillman
The Hillman Letter

Latest Letter

Weekly operator notes on healthcare regulatory strategy, compliance, and enforcement. Educational, not legal advice.

The Hillman Letter · Latest ·
Zero Was True. The Claim Was Still False.
Six SNG dialysis centers pay about $2 million after reporting zero revenue to HRSA without disclosing a pre-arranged sale or closure. A true number in a misleading context still supports a False Claims Act theory.
Read on Substack
The Hillman Letter ·
1.25-1.6x Beats Treble: The Six-Month FCA Self-Disclosure Window
DOJ and HHS just put a price tag on coming forward: a 1.25 to 1.6x repayment for disclosing previously unknown civil False Claims Act issues. The clock runs to April 22, 2027.
Read on Substack
The Hillman Letter ·
The Spreadsheet Knew
Two September and October settlements show how a stalled internal review turns into a False Claims Act case. The 60-day overpayment clock is the reason.
Read on Substack

More issues: Writing · Archive: thehillmanletter.substack.com

Publications

Andrew Jonathan Hillman's works are listed on ORCID 0009-0001-5396-321X and deposited on Zenodo with permanent DOIs.

Exosome and mesenchymal stem cell derived extracellular vesicle products are not approved by the FDA for any indication. The work referenced here describes published scientific literature. It does not describe an available treatment.

Expert witness page: Dallas Healthcare Compliance Expert Witness.

Andrew Jonathan Hillman

Dallas senior paralegal and healthcare compliance expert witness. Not an attorney.

Expert witness page · Publications · Q&A · Book a meeting

Also see andrew-hillman.com for the full profile and hillmanv.com for the investment office.

Profiles

Press

Sites